According to Merit Medical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.40251. At the end of 2023 the company had a P/S ratio of 3.49.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.49 | -0.1% |
2022 | 3.49 | 6.71% |
2021 | 3.27 | 2.3% |
2020 | 3.20 | 84.63% |
2019 | 1.73 | -50.07% |
2018 | 3.47 | 16.48% |
2017 | 2.98 | 52.27% |
2016 | 1.96 | 28.91% |
2015 | 1.52 | 2.36% |
2014 | 1.48 | -1.26% |
2013 | 1.50 | 0.26% |
2012 | 1.50 | -4% |
2011 | 1.56 | 3.01% |
2010 | 1.51 | -28.07% |
2009 | 2.11 | -4.91% |
2008 | 2.21 | 20.76% |
2007 | 1.83 | -20.15% |
2006 | 2.30 | 16.02% |
2005 | 1.98 | -25.79% |
2004 | 2.67 | -37.35% |
2003 | 4.26 | 79.18% |
2002 | 2.38 | 23.66% |
2001 | 1.92 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 3.79 | 11.26% | ๐บ๐ธ USA |
Medtronic MDT | 3.28 | -3.72% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 7.56 | 122.05% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 8.68 | 155.23% | ๐บ๐ธ USA |
Teleflex TFX | 3.28 | -3.74% | ๐บ๐ธ USA |
ICU Medical
ICUI | 1.02 | -69.88% | ๐บ๐ธ USA |
AngioDynamics ANGO | 0.7176 | -78.91% | ๐บ๐ธ USA |